Referred to the House Health Care & Wellness Committee on February 1, 2021
Substitute offered in the House on February 11, 2021
Provides that compounding of sterile or non-sterile products does not include reconstitution and mixing according to United States Food and Drug Administration–approved labeling if prepared pursuant to a prescription and, in the case of sterile products, administered immediately or in accordance with package labeling.